Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone: Tolerance and Safety Pilot Study
Phase of Trial: Phase II
Latest Information Update: 26 May 2017
At a glance
- Drugs Dexamethasone (Primary)
- Indications Hereditary corneal dystrophies; Keratoconus
- Focus Therapeutic Use
- Acronyms IDEXACOR
- 22 May 2017 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 22 May 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.
- 28 Nov 2016 Status changed from not yet recruiting to recruiting.